135 related articles for article (PubMed ID: 8578179)
21. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
Farley A; Wruble LD; Humphries TJ
Am J Gastroenterol; 2000 Aug; 95(8):1894-9. PubMed ID: 10950032
[TBL] [Abstract][Full Text] [Related]
22. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
Gallo S; Dibildox M; Moguel A; Di Silvio M; Rodríguez F; Almaguer I; García C
Rev Gastroenterol Mex; 1998; 63(1):11-6. PubMed ID: 10068743
[TBL] [Abstract][Full Text] [Related]
23. Identifying response to acid suppressive therapy in functional dyspepsia using a random starting day trial--is gastro-oesophageal reflux important?
Madsen LG; Wallin L; Bytzer P
Aliment Pharmacol Ther; 2004 Aug; 20(4):423-30. PubMed ID: 15298636
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Hatlebakk JG; Berstad A
Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
[TBL] [Abstract][Full Text] [Related]
25. Minimal differences in prevalence and spectrum of organic disease at upper gastrointestinal endoscopy between selected secondary care patients with symptoms of gastro-oesophageal reflux or dyspepsia.
Irvine AJ; Pinto-Sanchez MI; Bercik P; Moayyedi P; Ford AC
Scand J Gastroenterol; 2017 Apr; 52(4):396-402. PubMed ID: 27973922
[TBL] [Abstract][Full Text] [Related]
26. Effects of ranitidine treatment on patients with asthma and a history of gastro-oesophageal reflux: a double blind crossover study.
Ekström T; Lindgren BR; Tibbling L
Thorax; 1989 Jan; 44(1):19-23. PubMed ID: 2648642
[TBL] [Abstract][Full Text] [Related]
27. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
28. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
Carvalhinhos A; Fidalgo P; Freire A; Matos L
Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
[TBL] [Abstract][Full Text] [Related]
29. [Ranitidine therapeutically effective in functional dyspepsia with reflux-like symptoms].
Jebbink HJ; Smout AJ; van Berge Henegouwen GP
Ned Tijdschr Geneeskd; 1993 Aug; 137(35):1772-5. PubMed ID: 8371822
[TBL] [Abstract][Full Text] [Related]
30. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
Janiak P; Thumshirn M; Menne D; Fox M; Halim S; Fried M; Brühlmann P; Distler O; Schwizer W
Aliment Pharmacol Ther; 2007 Nov; 26(9):1259-65. PubMed ID: 17944740
[TBL] [Abstract][Full Text] [Related]
31. Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy.
Larson JD; Patatanian E; Miner PB; Rayburn WF; Robinson MG
Obstet Gynecol; 1997 Jul; 90(1):83-7. PubMed ID: 9207819
[TBL] [Abstract][Full Text] [Related]
32. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.
Venables TL; Newland RD; Patel AC; Hole J; Wilcock C; Turbitt ML
Scand J Gastroenterol; 1997 Oct; 32(10):965-73. PubMed ID: 9361167
[TBL] [Abstract][Full Text] [Related]
33. Rapid onset of effect of sodium alginate on gastro-oesophageal reflux compared with ranitidine and omeprazole, and relationship between symptoms and reflux episodes.
Dettmar PW; Sykes J; Little SL; Bryan J
Int J Clin Pract; 2006 Mar; 60(3):275-83. PubMed ID: 16494641
[TBL] [Abstract][Full Text] [Related]
34. The effect of ranitidine on symptom relief and quality of life of patients with gastro-oesophageal reflux disease.
Chal KL; Stacey JH; Sacks GE
Br J Clin Pract; 1995; 49(2):73-7. PubMed ID: 7779648
[TBL] [Abstract][Full Text] [Related]
35. Gastric secretion and reflux pattern in reflux oesophagitis before and during ranitidine treatment.
Johansson KE; Tibbling L
Scand J Gastroenterol; 1986 May; 21(4):487-92. PubMed ID: 3523741
[TBL] [Abstract][Full Text] [Related]
36. Gastro-oesophageal reflux symptoms--clinical findings and effect of ranitidine treatment.
Hallerbäck B; Glise H; Johansson B; Rosseland AR; Hultén S; Carling L; Knapstad LJ
Eur J Surg Suppl; 1998; (583):6-13. PubMed ID: 10027666
[TBL] [Abstract][Full Text] [Related]
37. Ranitidine, 75 mg, over-the-counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro-oesophageal reflux.
Orenstein SR; Blumer JL; Faessel HM; McGuire JA; Fung K; Li BU; Lavine JE; Grunow JE; Treem WR; Ciociola AA
Aliment Pharmacol Ther; 2002 May; 16(5):899-907. PubMed ID: 11966498
[TBL] [Abstract][Full Text] [Related]
38. Ambulatory pH monitoring of gastro-oesophageal reflux in "morning dipper" asthmatics.
Nagel RA; Brown P; Perks WH; Wilson RS; Kerr GD
BMJ; 1988 Nov; 297(6660):1371-3. PubMed ID: 3146369
[TBL] [Abstract][Full Text] [Related]
39. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
[TBL] [Abstract][Full Text] [Related]
40. [Comparison of the effects of Rocgel and anti-H2 on the symptomatology of gastroesophageal reflux without esophagitis].
Houcke P; Maffioli C; Corallo J; Bouxin-Sauzet A; Martin AL
Ann Gastroenterol Hepatol (Paris); 1995 Sep; 31(4):264-7. PubMed ID: 7486823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
